Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox cardiac T2* in beta-thalassemia
NCT00447694Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2006
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferasirox in iron overload, sponsored by Novartis. Started Feb 2006; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT00447694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447694.